| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 604.908 | 93 |
| GSM780708 | Untreated after 4 days (C2_1) | 692.808 | 94 |
| GSM780709 | Untreated after 4 days (C3_1) | 717.25 | 94 |
| GSM780719 | Untreated after 4 days (C1_2) | 591.435 | 93 |
| GSM780720 | Untreated after 4 days (C2_2) | 656.575 | 93 |
| GSM780721 | Untreated after 4 days (C3_2) | 703.887 | 94 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 573.742 | 92 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 588.483 | 93 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 662.233 | 93 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 642.104 | 93 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 675.106 | 94 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 653.924 | 93 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 641.285 | 93 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 589.711 | 93 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 538.126 | 92 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 665.307 | 93 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 578.385 | 93 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 606.274 | 93 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 701.169 | 94 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 581.817 | 93 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 595.966 | 93 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 657.766 | 93 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 613.732 | 93 |